MARCAP investigators conducted the first individual patient data meta-analysis of randomized trials (POSEIDON) evaluating the use and duration hormone therapy with postoperative radiation therapy in ...
(UroToday.com) The 2026 GU ASCO annual meeting featured a kidney cancer trials in progress session and a presentation by Dr. Laurence Albiges discussing REJOICE-PanTumor01, a phase 2 signal-seeking ...
Telix reported FY2025 revenue of $804M, up 56% YoY, with Precision Portfolio products Illuccix and Gozellix contributing $622M. Read why TLX stock is a Buy.
At 24 months overall survival was 62.8% with Welireg plus Lenvima versus 55.4% with Cabometyx. Median overall survival was 34 ...
According to Tang, this independence suggests that each biomarker provides unique prognostic information, making both valuable for understanding patient outcomes. Building on these findings, the ...
The treatment landscape for clear cell renal cell carcinoma (ccRCC) could be due for a shake-up following dual breakthroughs ...
Dosimetry data from the Phase 3 ECLIPSE substudy demonstrated favorable organ radiation absorbed doses supporting administration of 7.4 GBq for ...
Anticipated findings from the LITESPARK-011 trial (NCT04586231) to be presented during the 2026 ASCO Genitourinary Cancers ...
Brad Arnold, the lead singer and cofounder of rock band 3 Doors Down, has died, his bandmates confirmed Saturday, Feb. 7. He was 47. The founding member died peacefully alongside loved ones, including ...
Add Yahoo as a preferred source to see more of our stories on Google. Brad Arnold, lead singer and founding member of the multiplatinum rock band 3 Doors Down who wrote and sang the smash FM hits ...
Brad Arnold, the lead singer and founding member of the American rock band 3 Doors Down, died on Saturday after a battle with cancer. He was 47. A rep for Arnold said he died peacefully in his sleep, ...
Locally advanced ccRCC at stage III typically reflects T3 invasion into renal vein/IVC or perinephric fat, with optional N1 regional lymph node involvement, without distant metastases. Definitive risk ...